THE EFFECTS OF GLUCOSE, INSULIN AND METFORMIN ON THE ORDER PARAMETERS OF ISOLATED RED-CELL MEMBRANES - AN ELECTRON-PARAMAGNETIC RESONANCE SPECTROSCOPIC STUDY

被引:25
作者
FREISLEBEN, HJ [1 ]
RUCKERT, S [1 ]
WIERNSPERGER, N [1 ]
ZIMMER, G [1 ]
机构
[1] FA LIPHA,F-69008 LYONS,FRANCE
关键词
D O I
10.1016/0006-2952(92)90491-Z
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Human red blood cell (RBC) membranes (RBC ghosts) were treated with glucose, insulin and metformin. The order parameters of RBC membranes were determined by 5- and 16- doxyl-stearic acid spin labels. Metabolic effects were excluded using an isolated system of RBC membranes. The membranes were incubated with glucose in physiological (5 mM), renal threshold (10 mM) and manifested diabetic (20 mM) concentrations for limited times. High concentrations of glucose (10, 20, 100 mM) increase the order parameters of RBC membranes significantly. Insulin by itself has a similar effect which is, however, not strictly concentration-dependent. By contrast, metformin at therapeutic concentrations (0.5 and 5.0-mu-M) decreases the order parameters. At 50-mu-M concentration the metformin effect is expressed less and recurs at 100-mu-M concentration. The effects are significant with 5-doxyl-stearic acid, but are not significant with the 16-doxyl derivative. When RBC membranes are co-incubated with 20 mM glucose and metformin at 0.5 and 5.0-mu-M concentrations the order parameters as determined by 5-doxyl-stearic acid remain normal (= control values). Higher concentrations of metformin (50 and 100-mu-M) cause an overshoot to very low order parameters. Insulin at 10, 100 and 200 mU/L does not influence significantly the effects of metformin. Addition of physiological amounts of bovine serum albumin does not abolish the effects of metformin. Metformin, at therapeutic concentrations (0.5 and 5.0-mu-M), maintains the normal fluidity at the polar interface of isolated RBC membranes by counterbalancing non-enzymatic glycosylation with 20 mM glucose in vitro.
引用
收藏
页码:1185 / 1194
页数:10
相关论文
共 56 条
  • [1] NONENZYMATIC GLYCOSYLATION OF ERYTHROCYTIC PROTEINS IN NORMAL AND DIABETIC SUBJECTS - ENZYMES OF NUCLEOSIDE AND NUCLEOTIDE-METABOLISM
    AGARWAL, KC
    PARKS, RE
    WIDNESS, JA
    SCHWARTZ, R
    [J]. DIABETES, 1985, 34 (03) : 251 - 255
  • [2] HIGHER LEVELS OF ERYTHROCYTE-MEMBRANE MICROVISCOSITY IN DIABETES
    BABA, Y
    KAI, M
    KAMADA, T
    SETOYAMA, S
    OTSUJI, S
    [J]. DIABETES, 1979, 28 (12) : 1138 - 1140
  • [3] TREATMENT METFORMIN
    BAILEY, CJ
    NATTRASS, M
    [J]. BAILLIERES CLINICAL ENDOCRINOLOGY AND METABOLISM, 1988, 2 (02): : 455 - 476
  • [4] INSULIN EFFECTS ON HUMAN RED-BLOOD-CELLS
    BALDINI, P
    INCERPI, S
    PASCALE, E
    RINALDI, C
    VERNA, R
    LULY, P
    [J]. MOLECULAR AND CELLULAR ENDOCRINOLOGY, 1986, 46 (02) : 93 - 102
  • [5] CHANGES IN FLUIDITY AND COMPOSITION OF ERYTHROCYTE-MEMBRANES AND IN COMPOSITION OF PLASMA-LIPIDS IN TYPE-I DIABETES
    BRYSZEWSKA, M
    WATALA, C
    TORZECKA, W
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 1986, 62 (01) : 111 - 116
  • [6] ASSOCIATION BETWEEN THE GLYCATION OF ERYTHROCYTE-MEMBRANE PROTEINS AND MEMBRANE FLUIDITY
    BRYSZEWSKA, M
    SZOSLAND, K
    [J]. CLINICAL BIOCHEMISTRY, 1988, 21 (01) : 49 - 51
  • [7] PROTEIN GLYCOSYLATION AND THE PATHOGENESIS OF ATHEROSCLEROSIS
    CERAMI, A
    VLASSARA, H
    BROWNLEE, M
    [J]. METABOLISM-CLINICAL AND EXPERIMENTAL, 1985, 34 (12): : 37 - 44
  • [8] CERAMI A, 1979, METABOLISM, V28, P431, DOI 10.1016/0026-0495(79)90051-9
  • [9] COLANTUONI A, 1988, DIABETES METAB, V14, P549
  • [10] COLLIER A, 1989, DIABETES METAB, V15, P420